Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe ClinicalTrials.gov page remains an error page showing a 403 Forbidden message; its footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAccess to the NCT04173338 study record is replaced by a 403 Forbidden error, removing the study details and related content from the page. This change alters how users view the trial information by displaying an access-denied page instead of the study record.SummaryDifference17%

- Check51 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a site version update. The visible study information remains the same, with no changes to the study details on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedFDA-regulated drug and device indicators were added to the study record, along with an expanded set of MeSH terms and updated metadata such as study dates and enrollment. The previous error-page content was removed, and the page now displays the standard ClinicalTrials.gov study details for this trial.SummaryDifference43%

- Check72 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a backend or formatting update to the ClinicalTrials.gov page rather than a substantive change to the study content.SummaryDifference16%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.